Medspa Marketing Channel Benchmarks & CAC

Aesthetic demand is discretionary, price-sensitive, and highly concentrated in repeat customers. A single patient acquiring Botox or filler today may return 3–4 times annually; a non-responder costs you acquisition spend with zero lifetime value. Unlike medical practices, medspa revenue depends on converting first-time inquiries into loyal patients. This means your CAC directly determines whether a $400 treatment yields profit or loss. High CAC also compresses margins when patients shop price; low CAC (via referral or brand loyalty) enables premium positioning and higher margins.

Google Search and Meta (Facebook/Instagram) ads dominate paid acquisition in aesthetics. Search CAC typically ranges $80–$250 per qualified lead, depending on geography, competition, and treatment (injectables command higher CAC than laser). Social CAC is often lower per impression but requires higher ad spend to reach conversion—typically $120–$400 per booked appointment. Influencer partnerships and affiliate programs (e.g., partnerships with aesthetics educators or micro-influencers) can reduce CAC to $50–$150 per patient but require upfront content investment and vetting. Track cost-per-lead, cost-per-consultation, and cost-per-treatment separately; many practices conflate them, inflating perceived CAC.

Patient referral remains the lowest-CAC channel, often $0–$30 per new patient (only incentive cost). Practices with strong referral programs see 20–40% of new bookings from existing patients. Supplier-backed loyalty programs—such as Allē (AbbVie/Allergan), Aspire (Galderma), and Evolus Rewards—bundle patient incentives with practice rebates, effectively subsidizing acquisition. These programs reduce your direct CAC but tie you to supplier ecosystems; verify rebate terms and patient data access before committing. Google Local Services Ads and Yelp lead generation occupy a middle ground: $40–$120 per lead, with lower conversion friction but higher competition in dense markets.

CAC is not uniform. Urban markets (NYC, LA, Miami, Dallas) see 2–3× higher paid CAC due to competition; rural and suburban practices often acquire patients at $50–$150 per treatment via search and local referral. Injectables (Botox, filler) command higher CAC ($120–$300) than laser/energy-based treatments ($80–$180), because injectables attract price-conscious, comparison-shopping patients. Newer treatments (e.g., Skinvive by Juvéderm, RHA Dynamic Volume, Restylane Contour) initially carry premium CAC ($200–$400) due to low awareness; CAC drops as clinical data spreads and patient education scales. Seasonal variation is real: CAC peaks Jan–Feb (New Year's resolutions) and Sept–Oct (pre-holiday); summer and December often see lower CAC but also lower conversion rates.

Track CAC by channel, treatment, and patient cohort. Divide total marketing spend (ads, influencer fees, referral incentives, loyalty rebates) by new patients acquired in that channel over a defined period. Calculate CAC payback period: divide CAC by average patient lifetime value (LTV). If LTV is $2,000 (5 annual treatments × $400 average) and CAC is $150, payback is ~1 month—healthy. If CAC is $600, payback stretches to 3+ months, signaling inefficiency. Benchmark against your own baseline first, then peer practices in your market. Use UTM codes, call tracking, and CRM tags to attribute every patient to a source. Avoid vanity metrics (impressions, clicks); focus on cost-per-booked-appointment and cost-per-completed-treatment. Audit quarterly and reallocate spend to lowest-CAC channels.

Beware of inflated CAC claims from marketing agencies; they often exclude overhead, platform fees, or failed campaigns. Verify loyalty program terms with your supplier's legal/compliance team—some programs impose patient data restrictions or lock-in clauses. Influencer partnerships require clear FTC disclosure and vetting for brand alignment; unlicensed or unethical influencers can expose your practice to liability. Referral incentives must comply with state anti-kickback laws and your state medical board's rules on patient inducements. Consult your legal counsel before launching aggressive referral bonuses or co-marketing deals. GLP-1 weight-loss drugs (semaglutide, tirzepatide) are creating new demand for facial volume restoration (fillers, fat grafting); this is a high-CAC, high-LTV segment but requires specialized messaging and patient education.